Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web


  Free Subscription

Articles published in Lancet

Retrieve available abstracts of 39 articles:
HTML format
Text format

Single Articles

    December 2018
  1. CAMERON DA, Gelber RD, Procter M, Suter T, et al
    Concerns about cardiotoxicity in the HERA trial - Authors' reply.
    Lancet. 2018;390:2767-2768.
    PubMed     Text format    

  2. LEVY A, Chargari C, Deutsch E, Rivera S, et al
    Concerns about cardiotoxicity in the HERA trial.
    Lancet. 2018;390:2767.
    PubMed     Text format    

    October 2018
  3. MAYA Y, Tashimo A, Ota M
    Persistent red and swollen eyelids.
    Lancet. 2018;392:1552.
    PubMed     Text format    

    Ustekinumab: a promising new drug for SLE?
    Lancet. 2018;392:1284-1286.
    PubMed     Text format    

    A new powerful drug to combat river blindness.
    Lancet. 2018;392:1170-1172.
    PubMed     Text format    

  6. OPOKU NO, Bakajika DK, Kanza EM, Howard H, et al
    Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.
    Lancet. 2018;392:1207-1216.
    PubMed     Text format     Abstract available

    September 2018
  7. SCHADENDORF D, van Akkooi ACJ, Berking C, Griewank KG, et al
    Lancet. 2018;392:971-984.
    PubMed     Text format     Abstract available

  8. LEBWOHL B, Sanders DS, Green PH
    Coeliac disease and dermatitis herpetiformis - Authors' reply.
    Lancet. 2018;392:917.
    PubMed     Text format    

  9. RODRIGUES F, Bachmeyer C
    Coeliac disease and dermatitis herpetiformis.
    Lancet. 2018;392:916.
    PubMed     Text format    

  10. CAIO G, De Giorgio R, Volta U
    Coeliac disease and dermatitis herpetiformis.
    Lancet. 2018;392:916-917.
    PubMed     Text format    

  11. JANARTHANAN M, Rathinasamy J
    Aortic calcification in longstanding, undiagnosed Takayasu arteritis.
    Lancet. 2018;392:950.
    PubMed     Text format    

    August 2018
  12. LA PLACA M, Chessa MA
    Erythema multiforme major with swollen lips and crusted erosions.
    Lancet. 2018;392:592.
    PubMed     Text format    

  13. BURZA S, Croft SL, Boelaert M
    Lancet. 2018 Aug 17. pii: S0140-6736(18)31204.
    PubMed     Text format     Abstract available

  14. WILLER H
    Breast cancer in Venezuela: back to the 20th century.
    Lancet. 2018;392:461-462.
    PubMed     Text format    

  15. CLINE A, Feldman SR
    Risankizumab for psoriasis.
    Lancet. 2018 Aug 7. pii: S0140-6736(18)31781.
    PubMed     Text format    

  16. GORDON KB, Strober B, Lebwohl M, Augustin M, et al
    Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
    Lancet. 2018 Aug 7. pii: S0140-6736(18)31713.
    PubMed     Text format     Abstract available

    July 2018
  17. WALLACE DJ, Furie RA, Tanaka Y, Kalunian KC, et al
    Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Lancet. 2018;392:222-231.
    PubMed     Text format     Abstract available

    June 2018
  18. LIU XK, Li J
    Acral lentiginous melanoma.
    Lancet. 2018;391:e21.
    PubMed     Text format    

  19. SHEIKH S, Sasieni P
    When should the errors in the UK's breast screening programme have been spotted?
    Lancet. 2018;391:2319-2320.
    PubMed     Text format    

  20. DEODHAR A, Gottlieb AB, Boehncke WH, Dong B, et al
    Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study.
    Lancet. 2018;391:2213-2224.
    PubMed     Text format     Abstract available

  21. NASH P
    Psoriatic arthritis: novel targets add to a therapeutic renaissance.
    Lancet. 2018;391:2187-2189.
    PubMed     Text format    

    Psoriatic arthritis: classification and holistic management.
    Lancet. 2018;391:2185.
    PubMed     Text format    

  23. VAN DEN BOSCH F, Coates L
    Clinical management of psoriatic arthritis.
    Lancet. 2018;391:2285-2294.
    PubMed     Text format     Abstract available

  24. VEALE DJ, Fearon U
    The pathogenesis of psoriatic arthritis.
    Lancet. 2018;391:2273-2284.
    PubMed     Text format     Abstract available

  25. ZOU Y, Hu W, Zheng J, Pan M, et al
    Nail infestation: an atypical presentation of typical scabies.
    Lancet. 2018;391:2272.
    PubMed     Text format    

    April 2018
  26. MITJA O, Godornes C, Houinei W, Kapa A, et al
    Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study.
    Lancet. 2018;391:1599-1607.
    PubMed     Text format     Abstract available

  27. RIEDL MA, Relan A, Harper JR, Cicardi M, et al
    C1 esterase inhibitor concentrates and attenuated androgens - Authors' reply.
    Lancet. 2018;391:1356.
    PubMed     Text format    

  28. MULLER YD, Harr T, Dayer E, Seebach JD, et al
    C1 esterase inhibitor concentrates and attenuated androgens.
    Lancet. 2018;391:1355-1356.
    PubMed     Text format    

    February 2018
  29. SMAJS D, Pospisilova P
    Macrolide resistance in yaws.
    Lancet. 2018 Feb 7. pii: S0140-6736(18)30205.
    PubMed     Text format    

    January 2018
  30. VAIDYA JS, Bulsara M, Wenz F, Tobias JS, et al
    Targeted radiotherapy for early breast cancer.
    Lancet. 2018;391:26-27.
    PubMed     Text format    

    October 2017
  31. AERTS O, Herman A, Bruze M, Goossens A, et al
    FreeStyle Libre: contact irritation versus contact allergy.
    Lancet. 2017;390:1644.
    PubMed     Text format    

    July 2017
  32. SCHMITT AR, Wetter DA, Camilleri MJ, Khan SP, et al
    Langerhans cell histiocytosis presenting as a blueberry muffin rash.
    Lancet. 2017;390:155.
    PubMed     Text format    

    June 2017
  33. MEASE P
    New pathways of treatment for psoriatic arthritis.
    Lancet. 2017;389:2268-2270.
    PubMed     Text format    

    February 2017
  34. SPECHT JM, Davidson NE
    Optimal duration of trastuzumab for early HER2-positive breast cancer.
    Lancet. 2017 Feb 16. pii: S0140-6736(17)30322.
    PubMed     Text format    

  35. CAMERON D, Piccart-Gebhart MJ, Gelber RD, Procter M, et al
    11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial.
    Lancet. 2017 Feb 16. pii: S0140-6736(16)32616.
    PubMed     Text format     Abstract available

  36. PARES A
    An appealing new agent for treating cholestatic pruritus.
    Lancet. 2017 Feb 7. pii: S0140-6736(17)30320.
    PubMed     Text format    

  37. HEGADE VS, Kendrick SF, Dobbins RL, Miller SR, et al
    Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study.
    Lancet. 2017 Feb 7. pii: S0140-6736(17)30319.
    PubMed     Text format     Abstract available

    December 2016
  38. NATSUME O, Kabashima S, Nakazato J, Yamamoto-Hanada K, et al
    Two-step egg introduction for prevention of egg allergy in high-risk infants with eczema (PETIT): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2016 Dec 7. pii: S0140-6736(16)31418.
    PubMed     Text format     Abstract available

    November 2016
  39. HARBECK N, Gnant M
    Breast cancer.
    Lancet. 2016 Nov 16. pii: S0140-6736(16)31891.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.